Sign Up Today and Learn More About Cerevance Stock
Invest in or calculate the value of your shares in Cerevance or other pre-IPO companies through EquityZen's platform.
Cerevance Stock (CER)
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
About Cerevance Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
Cerevance Press Mentions
Stay in the know about the latest news on Cerevance
Cerevance Appoints Sagar Vaidya, M.D. Ph.D., as Chief Medical Officer
finance • Sep 20, 2024
Cerevance Appoints Sagar Vaidya, M.D. Ph.D., as Chief Medical Officer
globenewswire • Aug 12, 2024
Cerevance Achieves First Milestone in Research Collaboration with Merck
finance • Aug 05, 2024
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
globenewswire • Jun 26, 2024
Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline
globenewswire • Jun 26, 2024
Cerevance Management
Leadership team at Cerevance
Executive Director of Regulatory Affairs
Michelle Charles
Board Observer
Ben Robbins
Join now and verify your accreditation status to gain access to:
- Cerevance current valuation
- Cerevance stock price
- Available deals in Cerevance and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cerevance stock?
Accredited investors can buy pre-IPO stock in companies like Cerevance through EquityZen funds. These investments are made available by existing Cerevance shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cerevance stock?
Shareholders can sell their Cerevance stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
